AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 273 filers reported holding AVANOS MED INC in Q2 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,076 | +0.1% | 54 | 0.0% | 0.00% | – |
| Q1 2024 | $1,075 | -11.2% | 54 | 0.0% | 0.00% | – |
| Q4 2023 | $1,211 | +10.9% | 54 | 0.0% | 0.00% | – |
| Q3 2023 | $1,092 | -20.9% | 54 | 0.0% | 0.00% | – |
| Q2 2023 | $1,380 | -14.1% | 54 | 0.0% | 0.00% | – |
| Q1 2023 | $1,606 | +9.9% | 54 | 0.0% | 0.00% | – |
| Q4 2022 | $1,461 | -27.0% | 54 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $2,000 | +100.0% | 54 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 54 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 54 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 54 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $2,000 | 0.0% | 54 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $2,000 | 0.0% | 54 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $2,000 | 0.0% | 54 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,000 | 0.0% | 54 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,000 | 0.0% | 54 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,000 | +100.0% | 54 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 54 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $2,000 | – | 54 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,441,913 | $88,812,000 | 4.12% |
| RGM Capital, LLC | 2,157,612 | $78,472,000 | 3.63% |
| Millrace Asset Group, Inc. | 32,253 | $1,173,000 | 0.61% |
| HEARTLAND ADVISORS INC | 240,724 | $8,755,000 | 0.51% |
| Champlain Investment Partners, LLC | 2,607,033 | $94,818,000 | 0.45% |
| Campbell & CO Investment Adviser LLC | 27,200 | $989,000 | 0.41% |
| S.A. Mason LLC | 5,565 | $202,000 | 0.14% |
| XTX Topco Ltd | 8,240 | $300,000 | 0.10% |
| AIGEN INVESTMENT MANAGEMENT, LP | 15,186 | $552,000 | 0.10% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 16,875 | $614,000 | 0.09% |